Clinical Trials List
2022-01-19 - 2025-03-30
Phase I
Terminated2
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Chien-Chung Lin Division of General Internal Medicine
- Wen-Pin Su Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Po-Lan Su Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳教恩 Division of Hematology & Oncology
- 邱立忠 Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- 陳宏吉 Division of Ophthalmology
- Ching-His Siao Division of Ophthalmology
- Chih-Liang Wang Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
180 participants